Get the Stockscreener App
3.06
3.32%
-0.105
Optimi Health Corp stock is traded at $3.06, with a volume of 10,505.
It is down -3.32% in the last 24 hours and down -39.64% over the past month.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
See More
Previous Close:
$3.165
Open:
$3.24
24h Volume:
10,505
Relative Volume:
0.32
Market Cap:
$17.52M
Revenue:
$257.00K
Net Income/Loss:
$-3.07M
P/E Ratio:
-3.2119
EPS:
-0.9527
Net Cash Flow:
$-1.40M
1W Performance:
-25.09%
1M Performance:
-39.64%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$3.06
$3.44
1-Week Range:
$3.04
$4.20
52-Week Range:
$3.04
$6.40
Optimi Health Corp Stock (OPTH) Company Profile
Compare OPTH vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPTH
Optimi Health Corp
|
3.06 | 17.52M | 257.00K | -3.07M | -1.40M | -0.9527 |
TAK
Takeda Pharmaceutical Co Adr
|
19.64 | 62.73B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.26 | 48.12B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.965 | 43.82B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
78.69 | 32.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.00 | 23.55B | 3.17B | 1.29B | 1.01B | 27.09 |
Optimi Health Corp Stock (OPTH) Latest News
Optimi Health to Present at the ThinkEquity Conference - GlobeNewswire Inc.
Optimi Health Corp. (OPTI.CN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Optimi Health releases 5 mg psilocybin batch for Canadian Phase 2 trial - mugglehead.com
Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - kalkine.com.au
Optimi Health Corp. Plans Health Canada-Authorized Phase 3 Trial of MDMA-Assisted Therapy for PTSD - Quiver Quantitative
Optimi Health Corp Share PriceOPTI, RNS News, Articles, Quotes, & Charts (CNSX:OPTI) - Proactive financial news
OPTI: Commercially supplying natural psychedelics, expanding globally as regulations advance - TradingView
Optimi Health at H.C. Wainwright conference: early lead in psychedelics - Investing.com
OPTI: Commercial psychedelic manufacturer expands globally as regulatory momentum accelerates - TradingView
Optimi Health Corp. (CN:OPTI) Advances as Psychedelic Medicine Pipeline and Clinical Expansion Improve Investor Sentiment - kalkine.ca
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com Nigeria
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com South Africa
OPTH Stock Price, Quote & News - Syfe
OPTH Looks 64.2% Overvalued on GF Value™ - GuruFocus
Optimi Health Launches Health Canada-Authorized Phase 2 Psilocybin Trial for Major Depressive Disorder - kalkine.ca
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com Canada
Optimi Health To Initiate Phase 2 Psilocybin Trial For Major Depression - RTTNews
Optimi Health plans phase 2 psilocybin trial for depression - Investing.com
Optimi Health CorpTrial Initiation Planned For H1 2027, Dosing To Complete By End Of 2027 - TradingView
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com India
Optimi Health Announces Health Canada-Authorized Phase 2 Trial of Natural Psilocybin for Major Depressive Disorder - Quiver Quantitative
A 200-person psilocybin depression trial is coming from Optimi Health (OPTH); here’s when and where - Stock Titan
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder - Yahoo Finance
Optimi Health Stock Under Pressure: Can Psychedelic Growth Overcome Rising Execution and Funding Risks? - kalkine.ca
Optimi Health to Present at H.C. Wainwright Global Investment Conference - TipRanks
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Investing News Network
Optimi Health Corp. to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca
Psychedelic-drug maker Optimi Health (OPTH) plans investor meetings in New York - Stock Titan
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Optimi Health Stock Faces Renewed Pressure as Psychedelic-Sector Sentiment Weakens - kalkine.ca
Optimi Health (CN:OPTI) Drops 4.12% as Revenue Weakness, Funding Risk and Psychedelic-Sector Uncertainty Pressure Sentiment - kalkine.ca
Optimi Health Corp (CN: OPTI) Share Price, OPTI Stock News, OPTI Share Price & Updates - kalkine.ca
Optimi Health (OPTH) lines up discounted share funding with new $100M facility - Stock Titan
Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - kalkine.ca
Optimi Health Corp. SEC Filing (Aug 26, 2026) - Stock Titan
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now - Yahoo! Finance Canada
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now - Yahoo Finance
Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances - Yahoo Finance
Optimi Health (OPTH) Stock Chart and Price History 2026 - MarketBeat
Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion - TipRanks
Optimi Health (OPTH) clears way for resale of shares over 3x its float - Stock Titan
Optimi Health (OPTH) secures US$100M equity line with convertible note sweeteners - Stock Titan
Optimi Health Corp. Establishes US$100 Million Discretionary Equity Line of Credit with Seven Knots - kalkine.ca
Optimi Health (OPTH) raises $20.7M, posts larger loss and builds cash buffer - Stock Titan
Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots | OPTH Stock News - Quiver Quantitative
Optimi Health Establishes Discretionary Equity Facility - Yahoo Finance
Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots - Quiver Quantitative
Optimi Health Establishes Discretionary Equity Facility - globenewswire.com
Norton Rose Fulbright advises Optimi Health on equity facility - Norton Rose Fulbright
Norton Rose Fulbright advises Optimi Health on equity facility - Norton Rose Fulbright
Optimi Health Corp Stock (OPTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
2.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):